GianolaS, JesusTS, BargeriS. Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic. PLoS One2020; 15: e0240123.
4.
GuptaL, GasparyanAY, MisraDP. Information and misinformation on COVID-19: a cross-sectional survey study. J Korean Med Sci2020; 35: e256.
5.
GuptaL, GasparyanAY, ZimbaO. Scholarly publishing and journal targeting in the time of the coronavirus disease 2019 (COVID-19) pandemic: a cross-sectional survey of rheumatologists and other specialists. Rheumatol Int2020; 40: 2023–30.
6.
AñazcoD, NicolaldeB, EspinosaI. Publication rate and citation counts for preprints released during the COVID-19 pandemic: the good, the bad and the ugly. Peer J2021; 9: e10927.
7.
BeroL, LawrenceR, LeslieL. Cross-sectional study of preprints and final journal publications from COVID-19 studies: discrepancies in results reporting and spin in interpretation. BMJ Open2021; 11: e051821.
8.
MisraDP, AgarwalV. Integrity of clinical research conduct, reporting, publishing, and post-publication promotion in rheumatology. Clin Rheumatol2020; 39: 1049–60.